Biotech CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition December 11, 2022
Biotech Bellicum Announces Presentation by UNC at ASH 2022 on Potential Abrogation of iC9 CAR T-Cell Toxicities with Rimiducid December 11, 2022
Biotech ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 10, 2022
Biotech Affimed Reports Topline Data from AFM13 Monotherapy Phase 2 REDIRECT Study in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma December 10, 2022
Biotech Affimed Provides Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at the ASH 2022 Annual Meeting December 10, 2022
Biotech EIGR INVESTOR NEWS: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 9, 2022
Biotech Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 December 9, 2022
Biotech ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares December 9, 2022
Biotech CLASS ACTION UPDATE for EIGR, CURV and IREN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 9, 2022
Search
biotech
December 11, 2022
December 11, 2022
December 10, 2022
December 10, 2022
December 10, 2022
December 9, 2022
December 9, 2022
December 9, 2022
December 9, 2022
December 9, 2022
